GLIOBLASTOMA, WHO GRADE IV
Clinical trials for GLIOBLASTOMA, WHO GRADE IV explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, WHO GRADE IV trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, WHO GRADE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test triple attack on deadly brain cancer
Disease control OngoingThis study is testing if adding an immunotherapy drug (pembrolizumab) to two standard treatments can help people with a newly diagnosed, aggressive brain cancer (glioblastoma) live longer without their cancer getting worse. It will involve about 40 adults who have already had sur…
Matched conditions: GLIOBLASTOMA, WHO GRADE IV
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Early brain cancer trial seeks to boost radiation power
Disease control OngoingThis early-stage study is testing whether a drug called quisinostat can effectively reach brain tumor tissue when given alongside standard radiation therapy. It is for adults with a specific, aggressive type of brain cancer called IDH-wildtype glioblastoma, either newly diagnosed…
Matched conditions: GLIOBLASTOMA, WHO GRADE IV
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC